Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma
Managing common toxicities associated with checkpoint inhibitors and chemotherapy in untreated classic Hodgkin lymphoma (Figure generated in Biorender).